This is a Featured Course!
Understanding Novel Oral Anticoagulants (NOACs) Webinar Series - PART 1
- : Chatswood NSW 2067
Duration: This webinar goes for 1 hour followed by the interactive Q&A session.Speaker
Dr Jordan Fulcher completed his cardiology specialty training at Royal Alfred Hospital in 2013. He completed a Masters in Clinical Trials Research in 2015 and is involved in ongoing research on statins, cholesterol and the risk of cardiovascular disease at the University of Sydney. Dr Fulcher currently works as a VMO cardiologist and is an Honorary VMO at Royal Prince Alfred Hospital. Dr Fulcher has worked regionally in Orange and Coffs Harbour as a locum consultant and VMO cardiologist over the last several years.Overview
NOACs are widely prescribed to prevent stroke in non-valvular atrial fibrillation. While no clinical trials have directly compared these agents with each other, a number of recent observational studies have used real-world data from the USA and Europe to evaluate the safety and efficacy of each NOAC.
This webinar discusses the safety and efficacy outcomes for each of the three NOACs available in Australia, what these outcomes mean for choosing a NOAC in your patients, and the role of reversal agents in anticoagulant choice.
This webinar includes an opportunity for all participants to take part in an interactive Q&A with host speaker Dr Jordan Fulcher.
This education is an RACGP accredited activity.